Clinical Study Results
Research Sponsor: AstraZeneca AB
Drug Studied: Adavosertib, also called AZD1775
Study Title: A study to learn about the safety of adavosertib in participants with
solid tumors
Thank you!
Thank you to the participants who took part in the clinical study for the study drug
adavosertib, also called AZD1775.
AstraZeneca AB sponsored this study and thinks it is important to share the results. An
independent non-profit organization called CISCRP helped prepare this summary of the
study results for you.
If you participated in the study and have questions about the results, please speak with
the doctor or staff at your study site.
What is happening with the study now?
The study started in October 2017 and ended in May 2019. The sponsor reviewed the data
collected when the study ended and created a report of the results. This is a summary of
that report.
The study included 48 participants in France, the Netherlands, the United Kingdom, and
the United States who had participated in earlier studies on adavosertib.
1